Analyst
Ashka Investment Managers
Equibles does not estimate personal net worth.
Nirali Shah is recorded as Analyst at Ashka Investment Managers. Nirali Shah has spoken on 2 earnings calls across 2 companies, most recently for Gujarat Themis Biosyn Limited on August 10, 2026. Those appearances were for Gujarat Themis Biosyn Limited and Bajaj Healthcare Limited. The companies whose calls Nirali Shah spoke on are classified in the Healthcare sector.
“The second question is on the, so we are seeing a global product market shift from rifa-micin towards rifa-pentin. What is the downside to our existing rifa-micin as economics, and how much of that risk is offset by the Gujarat Samish moving downstream into rifa-pentin APIs?”
“First of all, congratulations on becoming the first company in India to receive the SEC recommendation. If you come back several hundred tablets, you own the regulatory milestone, which will help us understand the commercial opportunity, where we should focus primarily considering this opportunity.”
Ashka Investment Managers
Analyst
Transcript header (unverified)
Gujarat Themis Biosyn Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Bajaj Healthcare Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Gujarat Themis Biosyn Limited
Earnings Call for the Quarter Ended June 30, 2026
Bajaj Healthcare Limited
